POMZP3
gene geneOn this page
Also known as POM-ZP3POM121
Summary
POMZP3 (POM121 and ZP3 fusion, HGNC:9203) is a protein-coding gene on chromosome 7q11.23, encoding POM121 and ZP3 fusion protein (Q6PJE2).
This gene appears to have resulted from a fusion of DNA sequences derived from 2 distinct loci, specifically through the duplication of two internal exons from the POM121 gene and four 3’ exons from the ZP3 gene. The 5’ end of this gene is similar to the 5` coding region of the POM121 gene which encodes an integral nuclear pore membrane protein. However, the protein encoded by this gene lacks the nuclear pore localization motif. The 3’ end of this gene is similar to the last 4 exons of the zona pellucida glycoprotein 3 (ZP3) gene and the encoded protein retains one zona pellucida domain. Multiple protein isoforms are encoded by transcript variants of this gene.
Source: NCBI Gene 22932 — RefSeq curated summary.
At a glance
- MANE Select transcript:
NM_012230
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:9203 |
| Approved symbol | POMZP3 |
| Name | POM121 and ZP3 fusion |
| Location | 7q11.23 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | POM-ZP3, POM121 |
| Ensembl gene | ENSG00000146707 |
| Ensembl biotype | protein_coding |
| OMIM | 600587 |
| Entrez | 22932 |
Gene structure
Transcript identifiers
Ensembl transcripts: 11 — 10 protein_coding, 1 nonsense_mediated_decay
ENST00000275569, ENST00000310842, ENST00000424818, ENST00000441393, ENST00000454397, ENST00000879744, ENST00000879745, ENST00000879746, ENST00000879747, ENST00000936948, ENST00000960016
RefSeq mRNA: 2 — MANE Select: NM_012230
NM_012230, NM_152992
CCDS: CCDS43606, CCDS5590
Canonical transcript exons
ENST00000310842 — 7 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001815655 | 76626708 | 76627279 |
| ENSE00002452471 | 76626000 | 76626215 |
| ENSE00002475922 | 76625522 | 76625683 |
| ENSE00003466845 | 76609986 | 76610215 |
| ENSE00003537628 | 76618183 | 76618300 |
| ENSE00003552604 | 76611454 | 76611591 |
| ENSE00003791055 | 76611722 | 76611813 |
Expression profiles
Bgee: expression breadth ubiquitous, 141 present calls, max score 89.78.
Top tissues by expression
141 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left testis | UBERON:0004533 | 89.78 | gold quality |
| right testis | UBERON:0004534 | 88.85 | gold quality |
| testis | UBERON:0000473 | 88.81 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 88.41 | gold quality |
| apex of heart | UBERON:0002098 | 88.36 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 87.00 | gold quality |
| cortical plate | UBERON:0005343 | 86.97 | gold quality |
| mucosa of stomach | UBERON:0001199 | 86.80 | gold quality |
| right coronary artery | UBERON:0001625 | 86.60 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 86.42 | gold quality |
| lower esophagus | UBERON:0013473 | 86.40 | gold quality |
| embryo | UBERON:0000922 | 86.02 | gold quality |
| ganglionic eminence | UBERON:0004023 | 86.02 | gold quality |
| gastrocnemius | UBERON:0001388 | 85.99 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 85.96 | gold quality |
| skeletal muscle organ | UBERON:0014892 | 85.81 | gold quality |
| muscle of leg | UBERON:0001383 | 85.77 | gold quality |
| popliteal artery | UBERON:0002250 | 85.75 | gold quality |
| tibial artery | UBERON:0007610 | 85.75 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 85.73 | gold quality |
| right ovary | UBERON:0002118 | 85.58 | gold quality |
| muscle tissue | UBERON:0002385 | 85.57 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 85.50 | gold quality |
| left ovary | UBERON:0002119 | 85.36 | gold quality |
| ascending aorta | UBERON:0001496 | 85.25 | gold quality |
| thoracic aorta | UBERON:0001515 | 85.08 | gold quality |
| cerebellum | UBERON:0002037 | 85.00 | gold quality |
| ovary | UBERON:0000992 | 84.99 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 84.99 | gold quality |
| cerebellar cortex | UBERON:0002129 | 84.91 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 2.80 |
| E-MTAB-6142 | no | 61.19 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
6 targeting POMZP3, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4659A-3P | 99.80 | 72.62 | 4248 |
| HSA-MIR-4659B-3P | 99.80 | 72.62 | 4248 |
| HSA-MIR-589-5P | 98.72 | 66.96 | 927 |
| HSA-MIR-138-1-3P | 98.25 | 67.89 | 867 |
| HSA-MIR-6773-3P | 98.17 | 65.51 | 1213 |
| HSA-MIR-6748-3P | 97.20 | 65.66 | 836 |
Cross-species orthologs
9 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | zp3e | ENSDARG00000016908 |
| danio_rerio | zp3b | ENSDARG00000039828 |
| danio_rerio | zp3a.1 | ENSDARG00000042129 |
| danio_rerio | zp3a.2 | ENSDARG00000042130 |
| danio_rerio | zp3.2 | ENSDARG00000090768 |
| danio_rerio | zp3 | ENSDARG00000114958 |
| danio_rerio | zp3.2 | ENSDARG00000115457 |
| mus_musculus | Zp3 | ENSMUSG00000004948 |
| rattus_norvegicus | Zp3 | ENSRNOG00000001434 |
Paralogs (1): ZP3 (ENSG00000188372)
Protein
Protein identifiers
POM121 and ZP3 fusion protein — Q6PJE2 (reviewed: Q6PJE2)
All UniProt accessions (4): Q6PJE2, C9J370, C9JER0, H7C4D5
UniProt curated annotations — full annotation on UniProt →
Tissue specificity. Expressed in spleen, thymus, pancreas, testis, ovary, small intestine, colon and lymphocytes.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q6PJE2-4 | 1 | yes |
| Q6PJE2-5 | 2 |
RefSeq proteins (2): NP_036362, NP_694537 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR042235 | ZP-C_dom | Homologous_superfamily |
| IPR055355 | ZP-C | Domain |
Pfam: PF00100
UniProt features (5 total): chain 1, region of interest 1, compositionally biased region 1, splice variant 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6PJE2-F1 | 73.49 | 0.39 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 321 (showing top):
MORF_DNMT1, REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS, GOBP_INTRACELLULAR_PROTEIN_TRANSPORT, REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM, TGCTGCT_MIR15A_MIR16_MIR15B_MIR195_MIR424_MIR497, GCANCTGNY_MYOD_Q6, REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP, MORF_RRM1, GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP, MORF_UBE2N, GENTILE_RESPONSE_CLUSTER_D3, MORF_HDAC2, RIZKI_TUMOR_INVASIVENESS_3D_DN, GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_ORGANELLE
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (2): nucleoplasm (GO:0005654), nuclear membrane (GO:0031965)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| nuclear lumen | 1 |
| cellular anatomical structure | 1 |
| nucleus | 1 |
| nuclear envelope | 1 |
| organelle membrane | 1 |
Protein interactions and networks
STRING
280 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| POMZP3 | OR4L1 | Q8NH43 | 507 |
| POMZP3 | FRG2B | Q96QU4 | 474 |
| POMZP3 | ZP1 | P60852 | 445 |
| POMZP3 | DNAAF8 | Q8IYS4 | 431 |
| POMZP3 | ZP4 | Q12836 | 404 |
| POMZP3 | ZP2 | Q05996 | 387 |
| POMZP3 | OR5A2 | Q8NGI9 | 379 |
| POMZP3 | ZNF708 | P17019 | 375 |
| POMZP3 | ZAR1 | Q86SH2 | 375 |
| POMZP3 | FAM171B | Q6P995 | 372 |
| POMZP3 | CLEC2L | P0C7M8 | 370 |
| POMZP3 | HRCT1 | Q6UXD1 | 370 |
| POMZP3 | HSD17B12 | Q53GQ0 | 352 |
| POMZP3 | FBRSL1 | Q9HCM7 | 350 |
| POMZP3 | C4BPB | P20851 | 349 |
IntAct
6 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| POMZP3 | ADORA2A | psi-mi:“MI:0915”(physical association) | 0.370 |
| POMZP3 | NMI | psi-mi:“MI:0915”(physical association) | 0.370 |
| KPNA2 | POM121C | psi-mi:“MI:0914”(association) | 0.350 |
| POMZP3 | PRRC2A | psi-mi:“MI:0914”(association) | 0.350 |
| SLC25A25 | HAX1 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (11): POMZP3 (Two-hybrid), NMI (Two-hybrid), POMZP3 (Proximity Label-MS), POMZP3 (Two-hybrid), ATXN3 (Affinity Capture-MS), PRRC2A (Affinity Capture-MS), POMZP3 (Affinity Capture-MS), POMZP3 (Affinity Capture-MS), POMZP3 (Affinity Capture-RNA), APP (Reconstituted Complex), POMZP3 (Two-hybrid)
ESM2 similar proteins: A0A0D9SF12, A0A1Z2R986, A2AWH2, A6QNY1, C3VD30, D3ZF92, E7F5F0, E7FKV8, M3WHG5, O55034, O70303, O75509, O76081, O88393, O94966, P26342, P35054, P35125, P49763, P79209, P97946, Q03167, Q0VFL4, Q3T191, Q3UPF5, Q4TUC0, Q503Y8, Q5EB20, Q5M889, Q5XI33, Q62005, Q6B9Z1, Q6PJE2, Q6UWQ7, Q6UWV7, Q7TP54, Q7Z2W4, Q810F8, Q91V27, Q91ZV2
Diamond homologs: A6NF01, A6NNC1, A8CG34, P52591, Q3SYA9, Q6PJE2, Q8K3Z9, Q96HA1, Q96KW2, P10761, P21754, P23491, P42098, P48830, P48831, P48832, P48833, P53785, P53786, P79762, P97708, G5E8D7, Q60997, Q8CIZ5, Q95218, Q8N7R1, Q5SW25
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
0 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
847 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 7:76610213:TCA:T | acceptor_gain | 1.0000 |
| 7:76610214:CA:C | acceptor_gain | 1.0000 |
| 7:76610214:CACTG:C | acceptor_gain | 1.0000 |
| 7:76610216:C:CC | acceptor_gain | 1.0000 |
| 7:76611587:ACCAG:A | acceptor_gain | 1.0000 |
| 7:76611588:CCAG:C | acceptor_gain | 1.0000 |
| 7:76611588:CCAGC:C | acceptor_gain | 1.0000 |
| 7:76611589:CAG:C | acceptor_gain | 1.0000 |
| 7:76611589:CAGC:C | acceptor_gain | 1.0000 |
| 7:76611590:A:T | acceptor_gain | 1.0000 |
| 7:76611592:C:CC | acceptor_gain | 1.0000 |
| 7:76611717:CTCA:C | donor_loss | 1.0000 |
| 7:76611718:TCA:T | donor_loss | 1.0000 |
| 7:76611719:CAC:C | donor_loss | 1.0000 |
| 7:76611720:ACC:A | donor_loss | 1.0000 |
| 7:76611721:C:T | donor_loss | 1.0000 |
| 7:76611811:TAT:T | acceptor_gain | 1.0000 |
| 7:76611813:TCTGC:T | acceptor_loss | 1.0000 |
| 7:76611814:C:CC | acceptor_gain | 1.0000 |
| 7:76611814:CT:C | acceptor_loss | 1.0000 |
| 7:76611815:T:A | acceptor_loss | 1.0000 |
| 7:76618177:TCTTA:T | donor_loss | 1.0000 |
| 7:76618178:CTTAC:C | donor_loss | 1.0000 |
| 7:76618179:TTA:T | donor_loss | 1.0000 |
| 7:76618180:TA:T | donor_loss | 1.0000 |
| 7:76618298:CAG:C | acceptor_gain | 1.0000 |
| 7:76618298:CAGCT:C | acceptor_gain | 1.0000 |
| 7:76618301:C:CC | acceptor_gain | 1.0000 |
| 7:76618302:T:C | acceptor_gain | 1.0000 |
| 7:76618302:T:TC | acceptor_gain | 1.0000 |
AlphaMissense
1236 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 7:76611739:G:C | F140L | 0.971 |
| 7:76611739:G:T | F140L | 0.971 |
| 7:76611741:A:G | F140L | 0.971 |
| 7:76611751:C:A | K136N | 0.971 |
| 7:76611751:C:G | K136N | 0.971 |
| 7:76618261:G:C | F89L | 0.970 |
| 7:76618261:G:T | F89L | 0.970 |
| 7:76618263:A:G | F89L | 0.970 |
| 7:76618210:G:C | F106L | 0.969 |
| 7:76618210:G:T | F106L | 0.969 |
| 7:76618212:A:G | F106L | 0.969 |
| 7:76618204:A:C | F108L | 0.962 |
| 7:76618204:A:T | F108L | 0.962 |
| 7:76618206:A:G | F108L | 0.962 |
| 7:76618226:A:G | F101S | 0.961 |
| 7:76611588:C:A | W147C | 0.946 |
| 7:76611588:C:G | W147C | 0.946 |
| 7:76618225:G:C | F101L | 0.946 |
| 7:76618225:G:T | F101L | 0.946 |
| 7:76618227:A:G | F101L | 0.946 |
| 7:76618205:A:C | F108C | 0.928 |
| 7:76618262:A:C | F89C | 0.926 |
| 7:76611590:A:G | W147R | 0.924 |
| 7:76611590:A:T | W147R | 0.924 |
| 7:76611794:A:G | L122P | 0.921 |
| 7:76611744:A:G | S139P | 0.918 |
| 7:76611746:C:G | C138S | 0.917 |
| 7:76611747:A:T | C138S | 0.917 |
| 7:76618226:A:C | F101C | 0.904 |
| 7:76611801:A:G | C120R | 0.900 |
dbSNP variants (sampled 300 via entrez): RS1000170647 (7:76623101 G>C), RS1000431024 (7:76627404 G>T), RS1000484378 (7:76613439 G>A), RS1001087092 (7:76618698 T>C), RS1001181895 (7:76624124 G>A), RS1001212920 (7:76623830 A>C,G), RS1001601998 (7:76618555 AG>A,AGG), RS1002201698 (7:76619328 CA>C), RS1002244778 (7:76624761 A>G), RS1002990483 (7:76610818 C>G,T), RS1003094735 (7:76621155 G>A,T), RS1003295990 (7:76625769 C>A,G,T), RS1003432590 (7:76610523 A>G), RS1003675661 (7:76626055 T>C), RS1004036691 (7:76611889 A>C,G)
Disease associations
OMIM: gene MIM:600587 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
24 total (human), top 24 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | increases expression | 1 |
| bisphenol A | increases expression | 1 |
| cobaltous chloride | decreases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| JP8 aviation fuel | decreases expression | 1 |
| abrine | increases expression | 1 |
| 4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid | decreases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Benzo(a)pyrene | increases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Endosulfan | increases expression | 1 |
| Ethyl Methanesulfonate | increases expression | 1 |
| Etoposide | affects response to substance | 1 |
| Formaldehyde | increases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Mitoxantrone | affects response to substance | 1 |
| Smoke | decreases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Valproic Acid | increases expression | 1 |
| 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | increases expression | 1 |
| Paclitaxel | affects response to substance | 1 |
| Copper Sulfate | increases expression | 1 |
| Lactic Acid | increases expression | 1 |
| Particulate Matter | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.